Fighting the FDA’s Final Rule on LDTs
CEO Laurie Menser discusses the Association for Molecular Pathology’s court case against the FDA’s rule on laboratory-developed tests.
Top of the News-lir
Subscribe today for access to
Articles and Reports
Getting Started with the FDA’s New LDT Rule
Experts explain what the phase-in process will look like—and how labs can get ahead of the game.
Transitioning the Clinical Lab
What clinical laboratory professionals need to know about healthcare provision for transgender and nonbinary patients
Singulex Test Could Wind Up Targeting Heart Disease Treatments
...
Already a member? Log in here
LabCorp Acquires Sequenom for $302 Million, Assumption of Debt
From - Laboratory Industry Report
LabCorp has announced plans to acquire esoteric laboratory Sequenom for $302 million in cash and an assumption of about…
Quest Reports Higher Quarterly Profit, But Revenue Is Flat
From - Laboratory Industry Report
Quest Diagnostics reported flat revenue growth but robust profits for the second quarter of…
Quest Diagnostics Has Published Enormous Lead Contamination Study
...
Already a member? Log in here
CMS Bars Theranos’ California Lab from Medicare Program
...
Already a member? Log in here
Transgenomic Tries to Jumpstart Business Model Again
...
Already a member? Log in here
Trovagene, University of Michigan Enter Pact to Focus on KRAS-Based Pancreatic Cancer Detection, Treatment
From - Laboratory Industry Report
Trovagene has entered into a pact with the University of Michigan Comprehensive Cancer Center in order to develop a molecular test for the earlier detection and…
AMP Examines Costs for Genomic Sequencing
...
Already a member? Log in here
Walgreens Terminates Contract With Theranos
...
Already a member? Log in here
Grifols Takes 20 percent Stake in Singulex
...
Already a member? Log in here